There is a particular kind of institutional memory that belongs only to places which have been shaped, repeatedly, by necessity. Townsville is such a place. At the turn of the twentieth century, the far north of Queensland was a frontier of human settlement pressing against the limits of what European bodies were believed capable of enduring — a zone of heat, humidity, and unfamiliar disease that demanded scientific attention before it would yield comfortably to habitation. The response to that demand established something quietly remarkable: the Australian Institute of Tropical Medicine, the first medical research institute in Australia, opened in Townsville, northern Queensland, in 1910, for the purpose of discovering if Europeans could live healthily in the tropics.

That founding question — whether human beings could adapt and survive in tropical conditions — now reads as a historical curiosity, coloured by the assumptions of its era. But the institutional impulse behind it was genuine and serious, and the infrastructure it created became the deep root from which James Cook University’s modern tropical health and medicine enterprise has grown. What began in a converted wardsman’s building on the grounds of the Townsville Hospital is today one of Australia’s most distinctive research operations: a multi-disciplinary, multi-campus enterprise that directs its science not only at North Queensland’s health challenges, but outward toward the Pacific, Southeast Asia, and the full belt of nations straddling the equator.

The civic significance of this is worth dwelling on. Tropical medicine research does not lend itself to the same public visibility as, say, reef science or indigenous cultural preservation. Its work is conducted in laboratories, insectaries, and remote field sites; its outputs are papers, vaccine candidates, and policy guidance rather than images or spectacle. Yet the diseases it investigates — malaria, dengue fever, hookworm, tuberculosis, neglected tropical parasitoses — represent some of the largest concentrations of preventable human suffering on earth. That a university in Townsville and Cairns sits at the centre of serious global efforts to address these diseases is a fact that ought to be better understood by Queenslanders, and by the broader public that benefits from it.

THE 1910 FOUNDATION AND ITS LONG AFTERMATH.

In 1910 the Australian Institute of Tropical Medicine was founded in Townsville. Its establishment arose from concerns for the health of workers and communities in northern Australia. Dengue fever was rife and other debilitating diseases were affecting the population. The institute’s first director, Dr Anton Breinl, arrived in Townsville on 1 January 1910. With laboratory assistant John Fielding, Breinl started work in a wardsman’s building in the grounds of Townsville Hospital.

Breinl was a formidable figure: Anton Breinl (2 July 1880 – 28 June 1944) was a medical practitioner and medical researcher, who established the Australian Institute of Tropical Medicine in Townsville, Queensland, Australia. He had come to Australia from the Liverpool School of Tropical Medicine, where he had worked on trypanosomiasis and helped develop an early treatment for sleeping sickness using an organic arsenical compound that later became a cornerstone in the early development of chemotherapy. The work of the Institute expanded as the scientists investigated diseases such as malaria, dengue fever, filariasis, typhoid, hookworm, many unidentified fevers, amoebic dysentery, tropical sprue, leprosy, yaws and gangosa.

This initiated the discipline of laboratory science in Australia, and saw Townsville become the birthplace of Australian biochemistry. The Institute grew substantially through the early 1910s. The building that housed the Australian Institute of Tropical Medicine was opened on 28 June 1913 by Queensland Governor Sir William MacGregor. MacGregor was himself a medical doctor who had practised in the tropics across Fiji, British New Guinea, and West Africa, lending the opening ceremony a pointed symbolism: the ceremony joined colonial governance and tropical science in a building designed explicitly to understand the human body in extreme climatic conditions.

The Institute’s story between 1910 and its closure in 1930 was not straightforwardly triumphant. By the First World War, it was already suffering due to the difficulty of retaining adequate staff during wartime and xenophobic concerns regarding Breinl’s heritage. Breinl, Austrian-born and German-speaking, faced sustained social hostility during the war years despite having volunteered for military service three times and having treated severe malaria cases sent from New Guinea without pay. The AITM closed in Townsville in 1930 and was incorporated into the University of Sydney’s School of Public Health and Tropical Medicine.

The original AITM building on Clifton Street in Townsville endures. The Australian Institute of Tropical Medicine Building is a heritage-listed laboratory at Clifton Street, Townsville CBD, City of Townsville, Queensland, Australia. It was built from approximately 1912 to 1913. It is also known as the Anton Breinl Centre and James Cook University Department of Public Health and Tropical Medicine Building. It was added to the Queensland Heritage Register on 21 October 1992. The building’s presence on the heritage register is not merely bureaucratic. It marks the site where Australian laboratory science began, in a colonial frontier city, in service of a question about human survival — a question that has not yet been fully answered, only reformulated.

THE REVIVAL: JCU AND THE RECONSTITUTION OF TROPICAL HEALTH RESEARCH.

The story did not resume until the 1980s. JCU re-established the Australian Institute of Tropical Medicine in 1987, after the Kerr White Report into research, public health and tropical health recommended such a facility was needed. The Institute was briefly named the Tropical Health Surveillance Unit before becoming the Anton Breinl Centre for Tropical Health and Medicine and later being incorporated into JCU’s Department of Public Health and Tropical Medicine.

James Cook University’s commitment to tropical health, medical research and public health training dates from the 1980s. The revived commitment, rooted in the same city and the same institutional lineage as the 1910 original, acquired new purpose as understanding of tropical disease burden deepened globally. By 2009, JCU broadened its tropical health facilities and research partnerships with the founding of the Queensland Tropical Health Alliance (QTHA), a Queensland Government initiative based at JCU. Funded by the Queensland Smart State Innovation Building Fund and with matching partner funds, QTHA brings together health research facilities and expertise from the Queensland Institute of Medical Research, James Cook University, the University of Queensland, Queensland University of Technology and Griffith University.

The decisive institutional step came in 2013. The Queensland Government and the Australian Research Council (ARC) funded the establishment of AITHM in 2013. The Australian Institute of Tropical Health and Medicine (AITHM) is a flagship research institute of James Cook University based in the tropics of northern Australia. Australia’s only dedicated tropical health and medicine research institute, AITHM was positioned to occupy institutional ground that no other Australian body could occupy: research embedded in the tropics themselves, conducted by scientists who live and work in the same climatic zone as the diseases they study.

In early 2012, AITHM received a commitment of $42.12 million from the Queensland Government to build essential infrastructure and bolster key research projects. The Queensland Government invested $21.49 million in AITHM Townsville and the Federal Government provided funding of $8 million, via the Australian Research Council’s Special Research Initiative Scheme. The Cairns building received separate investment: the Australian Government provided $18 million for the building via the Australian Research Council’s Special Research Initiative Scheme, while the Queensland Government contributed a further $6.5 million.

Based at James Cook University in northern Queensland, AITHM has key nodes in Townsville, Cairns and the Torres Strait. The Torres Strait node is particularly significant. On Thursday Island, the research and training facility is adjacent to the Torres Strait Hospital. This strategic positioning grants proximity to, and engagement with, communities and healthcare providers who bear the burden of some of the most pressing health challenges in the region — a population whose geographic isolation, combined with proximity to Papua New Guinea, creates both elevated disease exposure and structural barriers to conventional health service delivery.

THE RESEARCH SCOPE: FROM MOSQUITOES TO MOLECULES.

Australia’s only dedicated tropical health and medicine research institute, AITHM is focused on solving problems of importance to the tropics, leading to improvements in health systems and healthcare delivery, improved biosecurity, and enhanced health outcomes for Australians and our neighbouring tropical nations. The breadth of research required to fulfil that ambition is genuinely wide.

Vector-borne diseases — those transmitted by mosquitoes and other insects — occupy a central place in AITHM’s portfolio. AITHM researchers lead several multi-million dollar regional and global vector-borne diseases initiatives, including an International Centre of Excellence in Malaria Research (ICEMR), an Australian Centre of Research Excellence in Malaria Elimination (ACREME), Department of Foreign Affairs and Trade Product Development Partnerships and Partnerships for a Healthy Region. Malaria remains the dominant focus of this work given the disease’s catastrophic persistence in the region: Papua New Guinea has the highest burden of malaria in the Western Pacific region, with 1.5 million cases.

The mosquito itself is as much a subject of study as the pathogens it carries. AITHM’s Mosquito-Borne Diseases Group has invested substantially in entomological surveillance, particularly regarding the spread of invasive species into Australian territory. Aedes albopictus, a documented vector of dengue, Zika and chikungunya, is one of the fastest spreading invasive species worldwide, and was first detected in the Torres Strait in 2005. The presence of this species on Torres Strait islands represents a direct biosecurity threat — a line of potential disease transmission running from Southeast Asia through the Pacific and into Australian territory that requires constant monitoring and active countermeasures. The Mosquito-Borne Diseases Group is leading a consortium of 12 institutions to enable more effective arbovirus and malaria vector surveillance in up to 12 Pacific island countries. The program aims to drive sustainable improvements in vector surveillance and control programs that will have broad impacts to improve regional health security.

Beyond vector biology, AITHM’s research reaches into immunoparasitology and drug discovery in ways that connect North Queensland science to global pharmaceutical development. The work of Distinguished Professor Alex Loukas is particularly instructive as an illustration of how tropical research generates unexpected scientific value. Professor Loukas has been hunting for a vaccine against hookworms, a parasitic infection that affects more than 740 million people worldwide. The hookworm research, conducted from JCU’s Cairns campus, follows a dual track: developing vaccines to protect impoverished tropical populations from chronic infection, while simultaneously investigating whether proteins secreted by hookworms might be harnessed to treat inflammatory bowel disease and other autoimmune conditions prevalent in wealthy nations. Loukas and his colleague Dr Paul Giacomin are using their knowledge about hookworm proteins to develop novel medications via their startup biotech company, Macrobiome Therapeutics Pty Ltd, having found that a single protein from hookworms can prevent the onset of IBD and other inflammatory conditions such as rheumatoid arthritis.

The JCU team is one year into a five-year European Union-funded project under the research and innovation programme Horizon Europe. The project, known as WORMVACS2.0, is led by Leiden University Medical Centre in the Netherlands and involves research institutes, universities and companies from Europe, Africa and the United States. As an associated partner of the project, the JCU team aims to produce a prototype hookworm vaccine. The pathway from a Cairns laboratory to a European consortium coordinating clinical trials across three continents is not a self-evident one, but it reflects the leverage that specialisation in tropical biology confers. Knowledge that is peripheral to temperate-zone universities becomes central when the disease in question afflicts hundreds of millions of people in warm, humid climates.

CLIMATE CHANGE AND THE EXPANDING THREAT HORIZON.

AITHM’s central themes of Tropical Health Security, Diseases of High Burden, and Tropical Health Systems have never been more important to the future and security of Australia, as climate change and human migration significantly increase risks from emerging infectious diseases. This assessment is not rhetorical. As average temperatures rise across the southern hemisphere, the ecological conditions that sustain tropical disease vectors are extending southward, bringing diseases previously confined to equatorial and sub-tropical zones into populations with little historical exposure and limited immunity.

Scientists say humankind is on the cusp of developing vaccines to control many tropical infectious diseases — lifting much of the burden of disease in developing countries and alleviating the spread of infections caused by global travel and climate change. But vaccine development, however promising, follows rather than leads the shifting disease geography. The more immediate task is epidemiological surveillance and predictive modelling. AITHM researchers have contributed to this work in the Pacific specifically: a doctoral researcher at JCU’s AITHM led a study that projected drastic changes in meteorological variables as global mean annual temperature rises substantially above pre-industrial levels. “This means there will be drastic changes in meteorological variables, which will likely have an implication for the proliferation of disease vectors such as mosquitoes. The World Health Organisation says that between 2030 and 2050, an additional 250,000 deaths will be attributed to climate sensitive diseases such as water-borne and vector-borne diseases.”

For small island nations in the Pacific — nations whose geography, limited health budgets, and proximity to endemic disease zones places them in a structurally vulnerable position — the kind of research capacity that AITHM offers represents something close to an existential resource. JCU’s location in northern Queensland, physically close to these nations and climatically continuous with them, is what makes this partnership coherent. A research institute in Sydney or Melbourne could publish on Pacific disease burden; one in Townsville and Cairns can embed researchers in communities, track vectors in the field, build local scientific capacity, and respond rapidly to emerging outbreaks. That difference — between knowledge produced about a place and knowledge produced with and from a place — matters enormously for research quality and policy impact.

HEALTH SYSTEMS AND ABORIGINAL AND TORRES STRAIT ISLANDER COMMUNITIES.

AITHM’s research programs confront northern Australia’s major health security risks, tackle its worst health outcomes, develop better ways to deliver health services to remote communities and contribute to the development of northern Australia through research, knowledge infrastructure and commercialisation of research findings. Within that broad mandate, the health circumstances of Aboriginal and Torres Strait Islander communities represent an area of particular focus and particular urgency.

The name of Anton Breinl lives on at JCU with the Anton Breinl Research Centre for Health Systems Strengthening, founded in 2015. The Centre’s research and programs are aimed at strengthening health and health systems in rural, remote, tropical and Aboriginal and Torres Strait Islander communities with a range of partner organisations. Health systems strengthening is a distinct field from biomedical research — it concerns itself with how services are designed, delivered, funded, and experienced by communities rather than with the biology of disease agents — but the two fields are inseparable in practice when dealing with populations that face both elevated disease risk and structural barriers to care access.

JCU’s research focus is on meeting the priority health needs of northern Australia and its near tropical neighbours through research that makes a difference and training a workforce with the knowledge, skills and attitudes to respond to these priority health needs. The aim is to progress health equity in partnership with Aboriginal peoples and Torres Strait Islanders, rural and remote populations, tropical populations in neighbouring countries and other under-served groups.

This framing matters. Research institutions, even well-intentioned ones, can become extractive — drawing data from vulnerable communities without building the local capacity to act on findings or ensuring that research priorities reflect community concerns rather than institutional interests. JCU and AITHM have both articulated a model premised on partnership and capacity building, though the degree to which this aspiration is realised in practice is something that can only be assessed by the communities themselves. What is documentable is the institutional commitment and the structural choices — the Thursday Island facility, the Cairns campus, the Torres Strait research partnerships — that make genuine engagement physically possible.

In collaboration with Traditional Owners from North Queensland, researchers from AITHM have identified native plant compounds that could soon alleviate the symptoms of inflammatory bowel disease. Such collaborations, drawing on Indigenous ecological knowledge to inform biomedical research, represent one of the more interesting convergence points between tropical biodiversity and tropical medicine — a connection that JCU is positioned, perhaps better than any other institution, to pursue systematically.

TUBERCULOSIS, VACCINES, AND THE COLLABORATIVE SCIENCE OF NEGLECTED DISEASE.

Beyond malaria and hookworm, AITHM’s research portfolio encompasses tuberculosis — a disease of enormous global burden that receives insufficient scientific attention relative to its impact. The BCG vaccine has been the only available tuberculosis vaccine for more than a hundred years. Parasitic worms infect about 1.5 billion people and millions of livestock around the world, causing a range of health problems and significant economic losses. Researchers at AITHM have been working on improving the BCG vaccine, with Associate Professor Andreas Kupz described by the Queensland Government’s science capability directory as a global expert in vaccine development for tuberculosis.

The breadth of this portfolio — dengue, malaria, hookworm, tuberculosis, zoonotic disease, vector biology, health systems — reflects both the scope of tropical disease burden and the institutional decision to construct a genuinely multi-disciplinary institute rather than a narrow specialty centre. This is achieved through biomedical, molecular, genomic, epidemiological, entomological and health systems research that is undertaken within an integrated public health framework. The value of that integration is practical as much as philosophical. Disease control in the tropics rarely admits of single-discipline solutions; it requires the entomologist and the vaccinologist to communicate with the health systems researcher and the community health worker, in a chain from laboratory bench to village health post.

AITHM is a leading tropical health and medical research institute, dedicated to solving problems of major importance to tropical Australia, South-East Asia, the Pacific and the Tropics worldwide, leading to improvements in health outcomes and health service delivery, and contributing to growing prosperity in the region. The language of “growing prosperity” here is deliberate. Disease burden suppresses economic productivity, impedes educational attainment, and reduces the capacity of communities to build the governance infrastructure that sustains wellbeing. Treating disease is, in this sense, not separable from the broader project of regional development — a connection that is well understood in global health policy, and that JCU’s location in northern Queensland gives it particular authority to articulate.

THE CIVIC PERMANENCE OF A RESEARCH IDENTITY.

James Cook University’s tropical medicine enterprise is, in aggregate, something more than a collection of research programs. It is a sustained institutional commitment, grounded in place, to the proposition that the health challenges of tropical populations — in Queensland, in the Pacific, across the developing world — deserve the full resources of serious science. That commitment carries a lineage reaching back to 1910, to a converted wardsman’s building in Townsville, to an Austrian scientist who identified amoebic dysentery in New Guinea and made Townsville the birthplace of Australian biochemistry. The AITM was Australia’s first medical institute and Dr Breinl’s groundbreaking work with his small team of researchers initiated laboratory science in Australia.

The work continues, now distributed across a network of purpose-built facilities on two campuses and in the Torres Strait, connected through research partnerships spanning Papua New Guinea, Indonesia, the Solomon Islands, Fiji, and beyond. The location of AITHM within a research-intensive university, located in and dedicated to the tropics, enables AITHM to leverage existing intellectual capital, build research capacity and apply evidence to address real challenges and priorities in health and medicine relevant to people in the tropics worldwide.

Within the emerging onchain civic infrastructure being built around Queensland’s permanent digital identity layer, jcu.queensland represents the address at which this institutional identity can be anchored — a namespace that records not just the university’s administrative existence but the full weight of what that university has chosen to be: an institution oriented to the specific challenges of life in the tropics, and prepared to carry that orientation into every domain of its activity, from reef science to refugee health to the molecular biology of parasitic worms.

"JCU has a proud history of research and development relevant to the tropics, and the research AITHM undertakes will improve health in the tropics both within Australia and worldwide. There are extraordinary opportunities for Australian tropical medicine given Northern Australia's proximity to the fast-growing nations of the Asia-Pacific region."

These words, attributed to former JCU Vice Chancellor Professor Sandra Harding at the opening of AITHM’s Townsville facilities, carry a civic weight beyond institutional self-description. They articulate what it means for Queensland to occupy the geographic position it occupies — poised between the temperate south and the tropical north, between the wealthy and the underserved, between the diseases that affluence permits us to forget and those that press constantly against the borders of what we have built. JCU’s tropical medicine mission is one of the most consequential ways in which Queensland chooses to meet that position with seriousness.

The question of how that institutional identity is recorded, preserved, and made legible across time and across digital infrastructure is part of what jcu.queensland is designed to answer. Civic institutions that have spent more than a century building knowledge about the health of tropical populations deserve a permanent address, not a contingent one. The permanence is not incidental. It is, in some measure, the point.